BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Tim Anderson does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 AARDAardvark Therapeutics, Inc. Common Stock | Buy | $26.00 | Mar 2025 | −55.0% | Miss |
| AARDAardvark Therapeutics, Inc. Common Stock | Buy | $22.00 | Mar 2025 | −51.1% | Miss |
 GILDGilead Sciences Inc | Buy | $109.00 | Dec 2024 | +26.3% | Hit |
 MRNAModerna Inc | Sell | $41.00 | Dec 2024 | +41.2% | Hit |
 MRKMerck & Company Inc | Buy | $121.00 | Dec 2024 | −7.5% | Miss |
 LLYEli Lilly and Company | Buy | $997.00 | Dec 2024 | +16.8% | Hit |
 REGNRegeneron Pharmaceuticals Inc | Sell | $565.00 | Dec 2024 | +14.5% | Hit |
 AMGNAmgen Inc | Sell | $256.00 | Dec 2024 | −10.2% | Hit |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.